You just read:

Sanofi-aventis and Regeneron Report Positive Phase III Results With ZALTRAP™ (aflibercept) in Second-line Metastatic Colorectal Cancer

News provided by

Regeneron Pharmaceuticals, Inc.

Apr 26, 2011, 04:05 ET